Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2015

The Role of Leukocyte-Platelet Rich Fibrin in Human Alveolar
Ridge Preservation: A Randomized Clinical Trial
Thomas F. Glazier
Virginia Commonwealth University

Thomas C. Waldrop
Virginia Commonwealth University

John C. Gunsolley
Virginia Commonwealth University

Robert Sabatini
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Periodontics and Periodontology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/3735

This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass.
For more information, please contact libcompass@vcu.edu.

© Thomas Foster Glazier 2015
All Rights Reserved

THE ROLE OF LEUKOCYTE-PLATELET RICH FIBRIN IN HUMAN ALVEOLAR RIDGE
PRESERVATION: A RANDOMIZED CLINICAL TRIAL
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science
in Dentistry at Virginia Commonwealth University

By

THOMAS FOSTER GLAZIER
Bachelor of Science, University of Georgia, 2007
Doctor of Dental Surgery, Virginia Commonwealth University School of Dentistry, 2012

Director: THOMAS C. WALDROP, D.D.S., M.S.
RESIDENCY PROGRAM DIRECTOR, DEPARTMENT OF PERIODONTICS

Virginia Commonwealth University
Richmond, Virginia
June, 2015

Acknowledgement
Thank you so much to everyone that played a role in this study. You all were absolutely
paramount in its success. Thank you to the Alexander Fellowship and the VCU Department of
Periodontics for funding and support. Without such a generous gift none of this would be
possible. I would like to sincerely thank my research committee, our research support staff, and
my co-residents. I would like to thank everyone at Intra-Lock, Inc., Lifenet Health, and Salvin
Dental Specialties, Inc., for their continued intellectual support and donation of materials. Most
importantly, I would like to thank my family for all of their love and support, specifically, my
beautiful wife, Lauren!

ii

Table of Contents

Page
List of Tables…………………………………...…….…………………………….……………..v
List of Figures………...…...………..…………………………………….……………………....vi
Abstract…..…………………………….………………………..…………..……….………..…vii
Chapter
1

Introduction………..……………….....…………………..……………………..…….1

2

Methods and Materials………………………………..…..……………….………....6
Patient Selection…………………………………………………………………6
Surgical Intervention……..………………………………………………...……7
Measurements……………………………………………………………………8
Statistical Analysis……………………………………………………….……...9

3

Results………………………………………………………………………………11

4

Discussion…………………………………………………………………………...14

5

Conclusion…………………………………………………………………………..32

6

References…………………………………………………………………………...34

iii

List of Tables
Page
Table 1: Baseline Study Demographics………………………………………………………….40
Table 2: Pairwise correlations of Clinical Horizontal Measurements………………………….. 41
Table 3: Clinical Horizontal Change………………………………………………………………………………………………. 42
Table 4: Radiographic Horizontal Change ……………………………………………………...43
Table 5: Analysis of Variance- Horizontal Ridge Width ……………………………………….44
Table 6: Pairwise Correlations of Clinical Vertical Measurements …………………………….45
Table 7: Clinical Vertical Change……………………………………………………………….46
Table 8: Radiographic Vertical Change …………………………………………………………47
Table 9: Analysis of Variance- Clinical Lingual Mean Vertical ………………………………..48
Table 10: Outcome Variables by Group……………………………………………………….. 49
Table 11: Overall Mean Changes by Group ……………………………………………………50

iv

List of Figures
Page
Figure 1: Measurement Stent ……………………………………………………………………51
Figure 2: Radiographic Horizontal Measurements ……………………………………………...52
Figure 3: Radiographic Vertical Measurements ………………………………………………...53
Figure 4: L-PRF Surgical Group ………………………………………………………………...54
Figure 5: FDBA + Resorbable Collagen Membrane Group……………………………………..55

v

Abstract

THE ROLE OF LEUKOCYTE-PLATELET RICH FIBRIN IN HUMAN ALVEOLAR RIDGE
PRESERVATION: A RANDOMIZED CLINICAL TRIAL
By Thomas Foster Glazier, D.D.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science
in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, 2015

Major Director: Thomas C. Waldrop, D.D.S., M.S.
Residency Program Director, Department of Periodontics

PURPOSE: The aim of this study is to examine the healing of intact extraction sockets grafted
with leukocyte-platelet rich fibrin (L-PRF) as compared to sockets grafted with freeze-dried bone
allograft (FDBA) and a resorbable collagen barrier membrane (RCM).

METHODS: This prospective randomized, examiner blinded pilot study included 17 subjects
randomized to two treatment groups. Serum total cholesterol, low density lipoprotein (LDL), 25hydroxyvitamin-D3, and platelet counts were determined preoperatively in all subjects. The experimental
arm consisted of 8 posterior tooth-bounded intact extraction sites receiving L-PRF plugs. The control
group consisted of 9 posterior tooth-bounded intact extraction sites receiving FDBA and RCM. An acrylic
stent was fabricated to take duplicate clinical and CBCT measurements immediately post-extraction and
at time of implant placement. A repeat-measures analysis of variance was utilized for statistical analysi

RESULTS: The study failed to detect a clinical or radiographic difference between treatment
groups in horizontal or vertical ridge dimension changes. Serum cholesterol, LDL, 25-hydroxyvitaminD3, and buccal plate thickness had a non-significant effect on outcome measurements, although there was
a high prevalence of hyperlidpidemia and hypovitaminosis in the study population.

CONCLUSIONS: The alveolar ridge dimension changes in intact posterior extraction sockets
may be similar when either L-PRF or FDBA and RCM are utilized as socket grafting material. Although
there was a high prevalence of high cholesterol and low 25-hydroxyvitamin-D3 levels in the population,
this study failed to detect a significant correlation between preoperative serum levels and postoperative
ridge dimension changes.

Keywords: Platelet, bone, graft, cone beam computed tomography, fibrin

Introduction

Alveolar ridge deformation can result from the extraction of a tooth due to both hard and
soft tissue loss. This deformation, or resorption, is a functional and esthetic concern, especially
in the area of restorative implant and prosthetic dentistry. 1, 2 this deformation occurs with
resorption of the buccal and lingual external socket walls.2 Pietrokovski3 found that following
extractions in both the maxillary and mandibular arches, more resorption occurs from the buccal
ridge. Schropp4 found clinically and radiographically, at twelve months post-extraction, a fifty
percent reduction in alveolar ridge width (from 12mm to 5.9mm), with two-thirds of the
reduction occurring in the first three months. Ridge height, however, only slightly decreased (<
1mm). Ridge width resorption may increase in severity when the buccal plate of bone is thin or
absent.5, 6 McCall reported forty to sixty percent loss of original bone height and width within
two years following multiple extractions.7
In order to minimize ridge resorption and soft tissue recession, as well as maximize
formation of bone, many hard and soft tissue regenerative options are available for preserving
and correcting ridge defects, including ridge preservation. Ridge preservation, with the use of
grafted material, provides space maintenance in order to prevent tissue collapse and maintain a
healthy architecture for future restorative options.8 Grafting an extraction socket can result in
preservation of eighty five percent of the initial alveolar ridge dimensions.9
Multiple ridge preservation techniques are available, and no one technique is considered
superior to another.8 Grafting materials include autogenous bone, demineralized freeze-dried
bone allografts (DFDBA), freeze-dried bone allografts (FDBA), xenografts, bioactive glass,
1

hydroxyapatite and calcium sulphate.2 In a split mouth prospective study, Lekovic,10 found
1.50mm loss of alveolar height and 4.56mm loss of ridge width in extraction sites alone versus
only 0.38mm of vertical loss and 1.31mm loss of ridge width in sites preserved using a
bioabsorbable membrane after six months. Iasella et al11 found that non-molar extraction and
ridge preservation with FDBA and a type I resorbable collagen membrane resulted in a loss of
1.2±0.9mm compared to 2.6±2.3mm in extraction sites alone. Aimetti et al12 compared ridge
preservation with calcium sulfate to extractions alone and found a loss of 2.0 ±1.1mm versus
3.2±1.8mm in extraction sites alone. Kotsakis et al.13 randomized extraction sites to receive
nothing, an intrasocket bovine xenograft, or an intrasocket bone putty. Sites receiving nothing
lost a mean of 2.53mm. Sites receiving bovine xenograft lost a mean of 1.39mm, and those
receiving allograft bone putty lost a mean of 1.26mm.
Some variation in the literature following extraction with or without ridge preservation
has been explained by surgical technique, 10, 14 presence and thickness of buccal plate, 6 and
location within the arch.4, 15 However, there still appears to be a variable response in terms of
horizontal ridge resorption.
Recent animal studies suggest that insufficient serum levels of 25-hydroxyvitamin-D3
negatively impact peri-implant bone formation, osseointegration, implant stability, and bone to
implant contact. 16, 17 Furthermore, repletion of vitamin D following deficiency improves periimplant bone formation 17 and improves the strength of post-fracture calluses in elderly animals
18

with a biologically active metabolite of 25-hydroxyvitamin-D3 accumulating around fracture

sites.19 Epidemiological data suggests that the incidence and prevalence of insufficiency and
deficiency have increased with current prevalence estimates of seventy-four to eighty percent of
the United States population having some vitamin D abnormality.20 Cross-sectional data from
2

orthopedic literature suggests that vitamin D abnormalities may lead to complications in osseous
healing.21, 22
Low-density lipoprotein (LDL) can be cytotoxic to osteoblasts.23 Animals given a high
fat diet demonstrated increased mandibular alveolar bone porosity, less trabecular thickness, and
impaired osteoblasts associated with an average plasma cholesterol level of 136±7.36mg/dl as
compared to animals given a normal diet whose plasma cholesterol levels averaged 90.80 ±
4.33mg/dl.24 Cholesterol has been shown to influence the fate of mesenchymal stem cells
capable of differentiating into osteoblastic or adipocytic lineages that reside within bone marrow
stromal cell populations. It is believed that increases in dietary fat may alter marrow lipid
composition and subsequently influence marrow stromal cell phenotypes. 25
Leukocyte-Platelet Rich Fibrin (L-PRF) is a three-dimensional heterogenous fibrin “clot”
that contains greater than ninety-seven percent of platelets and greater than fifty percent of
leukocytes present in a nine milliliter whole venous blood draw.26 L-PRF has been shown to
stimulate cell growth and replication of human osteoblast-derived-osteoscarcoma cells, human
kertinocyte-derived carcinoma cells, and human fibroblast lung carcinoma cells, and to
upregulate osteocalcin and ostepontin (bone sialoprotein-1) in human osteoblast-derived
osteosarcoma cells in vitro.27 The natural fibrin polymerization method combined with the
centrifugal force enables entrapment of growth factors from platelets and cytokines from
leukocytes into the fibrin matrix.28 L-PRF has been shown to release the growth factors TGFβ-1,
PDGF-αβ, VEG-F, and thrombospondin-1, an important coagulation glycoprotein of the cellular
matrix, for 7 days after its preparation.29 In vivo, the effect had mixed success in hard tissue
regeneration. Gürbüzer et al30 found no difference of osteoblastic activity in third molar
extraction sites using scintographic evaluation at 4 weeks postoperatively, yet several authors
3

reported a positive effect in maxillary sinuses augmentations,31, 32 mandibular class II
furcations,33, 34 and intrabony defects.35, 36, 37
Cone beam computed tomography (CBCT) provides a three-dimensional image of the
dental and maxillofacial areas. CBCT is a useful tool to locate anatomical structures, support
diagnostic implant planning, and as a guide for dental surgery. From a CBCT image, reliable
linear measurements of dentomaxillofacial structures can be made. Therefore, CBCT has the
potential to evaluate the healing of alveolar ridge preservation procedures.38, 39
Several studies have evaluated the accuracy and reproducibility of linear measurements
made on cone beam computed tomographic images. Loubele et al40 compared the accuracy of
linear measurements of alveolar bone taken on Accuitomo CBCT images, multislice CT images,
and direct measurements on an ex vivo model and found no statistical differences between any of
the measurement methods. This point was later confirmed by Lund et al41 who also reported a
high level of agreement between measurements made by multiple observers.
Tomasi et al42reported a high correlation between linear measurements made with a
caliper and measurements made on a CBCT image. Although,Torres et al43 found that typical
CBCT images underestimate the true linear distance by sixteen to seventeen percent in the
horizontal plane and seven to eight percent in the vertical plane. Hashem et al44 also found no
differences between two different methods of capturing a CBCT image as compared to direct
measurements made on porcine hemimandibles. Shokri et al45 also found a high level of
agreement between actual measurements with a digital caliper and measurements made on
CBCT. They felt the most accurate horizontal measurements were made with slice thicknesses of
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four to five millimeters. They concluded that measurements made on slices less than four
millimeters may underestimate the actual distance.
Intraoral films, such as bite-wings and periapicals, provide a two-dimensional image
while computed tomography produces a three-dimensional image.46 CBCT obtains this image by
using a two-dimensional detector to scan the entire head, rather than stacking multiple slices as
in conventional computed tomography allowing for a more efficient, less expensive, and lower
energy output image.47 CBCT does not expend high radiation doses. The average radiation dose
of 0.585mSv is well below that of a conventional medical-grade CT scan but above that of
conventional dental radiographs. Cortical integrity and thickness, enlarged bone marrow spaces,
postextraction irregularities, and trabecular bone density have all been identified clearly in the
cross-sectional images produced by the CBCT.48
The aim of this prospective blinded pilot study is to clinically and radiographically
evaluate the healing of extraction sites grafted with either human freeze-dried mineralized
cortical allograft and a resorbable barrier membrane or L-PRF. A secondary aim is to evaluate
the impact of serum cholesterol and vitamin D3 on alveolar healing.

5

Methods and Materials

Study Population
The Institutional Review Board of Virginia Commonwealth University reviewed and approved
this research protocol. Recruited patients were referred to Virginia Commonwealth University
School of Dentistry Graduate Periodontics Clinic for dental extraction and alveolar ridge
preservation of a premolar or molar between July 2013 and December 2014.

Inclusion Criteria
Inclusion criteria were systemically healthy (ASA1 or 2) adults over the age of 18 with a normal
blood concentration of thrombocytes (150,000-450,000/µL) as determined by a preoperative
platelet count. Subjects enrolled required one or two premolar or molar extractions and alveolar
ridge preservation in preparation to receive a dental implant. Study teeth were bordered by intact
teeth with intact periodontal ligaments on both the mesial and distal.

Exclusion Criteria
Exclusion criteria include uncontrolled systemic illness that may affect healing or clotting such
as diabetes mellitus, immunocompromisations, ongoing chemo- or radiotherapy; active smokers;
patients with known allergies to freeze dried bone allograft or collagen membranes; pregnancy,
and any detectable loss of buccal or lingual cortex immediately following extraction.6
Following informed consent, whole venous blood was drawn to determine platelet count, total
cholesterol, LDL, and 25-Hydroxyvitamin-D3 (Virginia Commonwealth University Health
System, Clinical Pathology Lab). Alginate impressions were also taken of the arch containing the
study site to fabricate an acrylic radiographic/clinical measurement sent.
6

Surgical Intervention
All surgeries were performed by a resident surgeon under the direct supervision of a boardcertified periodontist. Teeth were extracted utilizing a minimally traumatic technique. Subjects
had one or two teeth extracted in a minimally traumatic manner utilizing periotomes and
sectioning of molars. No mucoperiosteal flaps were elevated at any time during the extraction
procedure. Following confirmation of intact buccal and lingual cortical plates, the surgeon
completed the assigned graft protocol. Three to eight months post-operatively, dental implants
were placed utilizing full thickness flaps. During implant osteotomy preparation, a 2x8mm core
of bone was harvested utilizing a trephine bur. Samples were immediately placed in 10% neutral
buffered formalin and stored for histologic analysis.

Control Group
Mineralized freeze-dried cortical bone allograft (Oragraft, Lifenet Health) with particle sizes
ranging from 250 to 750µm was hydrated in sterile saline and gently condensed to the level of
the pre-existing alveolar bone height taking care not to over fill. A trimmed resorbable crosslinked type I porcine collagen membrane (Renovix, Salvin Dental Specialties, Inc.) was used to
cover the socket. Sutures were utilized to secure the membrane beneath the supracrestal gingiva
on the buccal and lingual.

Test Group
54mL of venous whole blood was collected with a 21-gauge butterfly needle from the antecubital
fossa into 6 red-top vacutainers containing no anticoagulant or biomodifiers (A-PRF, Process for
7

PRF). Each 9mL sample was immediately centrifuged at 2700RPM for 12 minutes taking care to
begin centrifugation within one minute of the blood draw (Intra-Spin, Intra-Lock, Inc). Upon
completion of the spin, forceps were used to transfer the L-PRF to a sterile kidney dish. The red
blood corpuscle end was gently removed with a scraping action with the back of tissue scissors.
The L-PRF was then transferred to a specialized metal box designed to fabricate plugs and
membranes. L-PRF was processed into plugs by placing the L-PRF into the designated wells and
compressed with a weighted piston for 2 minutes. 31-37 L-PRF plugs were condensed into the
extraction site using sterile gauze and a bone condenser. The plugs were condensed to the level
of the surrounding free-gingival margin. Sites were sutured in a similar manner to those used in
the control group mainly utilized to retain the L-PRF. In all sites there was no coronal
advancement of the buccal flap and absolutely no attempt at primary closure.
All patients received normal verbal and written post-operative instructions. Only subjects from
the control groups received a seven day course of systemic post-operative antibiotics. All
subjects were prescribed analgesics on an individual basis. Subjects were instructed not to brush
the surgical area for the first 2 weeks post-operatively. Supragingival scaling of adjacent teeth
and reinstruction in oral hygiene was completed at two and four weeks post-operatively.

Measurements
All measurements were obtained by a single blinded examiner not involved in patient treatment.
All clinical and radiographic measurements were made utilizing an acrylic stent with
radiographic markers at each measurement location.
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Clinical Measurements
Immediately post-extraction (T1) and prior to flap reflection at implant placement (T2), clinical
bone sounding measurements were made under local anesthesia. Using a Weiss Modified
Castroviejo caliper, alveolar buccal-lingual ridge width was recorded at three different points
along the ridge---mesial (M), center (C), and distal (D) at 3mm apical to the buccal crest of bone.
The buccal plate thickness was recorded at baseline in the same location as the horizontal
measurements. Utilizing a UNC-15 periodontal probe, relative vertical measurements were taken
of the alveolar crest at the four line angles of the extraction socket---mesiobuccal (MB),
distobuccal (DB), mesiolingual (ML), and distolingual (DL). All clinical measurements were
made to the nearest half millimeter.

Radiographic Measurements
CBCT images were captured at two time points: immediately post-extraction and three to eight
months later when implants were placed (Carestream CS9300, Carestream Health). Horizontal
and vertical measurements were recorded in the sagittal plane at the locations described above.
All radiographic measurements were made following the conclusion of the trial, however, the
image taken immediately post-extraction was reviewed to confirm no loss of cortical plate. All
CBCT measurements were made to the nearest one tenth of a millimeter.

Statistical Analysis
The primary outcome variable of this prospective pilot study is change in alveolar ridge width
measured 3mm apical to the buccal alveolar crest. An a priori power analysis was computed
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based on the mean (±0.68) of the inter- and intragroup standard deviations of three recent
prospective trials on ridge preservation.13, 14, 49 With an alpha value of 0.050 and a proposed
sample size of n=15 per treatment arm, the study has a power of 79.9% to yield a statistically
significant result. This effect was selected as the smallest effect that would be important to
detect, in the sense that any smaller effect would not be of clinical or substantive significance. It
is assumed that this effect size is reasonable, in the sense that an effect of this magnitude could
be anticipated in this field of research.
Randomization was performed with a computer-generated randomization table that was only
available to the surgeon residents and never the measuring examiner.
This was a two-group pre-post experimental design using two measurement methods—clinical
and CBCT. The pre-post change in width and height was compared between the two groups
using Analysis of Co-Variance (ANCOVA).
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Results

A total of 19 subjects who met inclusion criteria supplying 21 study sites were enrolled in this
prospective randomized examiner blinded pilot study. Throughout the course of the trial three
patients with one study site each were lost to follow up, and one site was excluded due to cortical
plate loss following extraction. 16 subjects (8 males, 8 females) with an average age of
54.13±16.96 (years; mean±SD) supplying 17 extraction sites successfully completed the trial—
Table 1. There were no adverse events that occurred during the treatment. Eight subjects with
nine sites were randomized to the control group and received a socket graft of human
mineralized cortical bone allograft covered with a cross-linked type I porcine collagen membrane
left intentionally exposed. Eight patients with eight sites were randomized to the test group and
received a socket graft of L-PRF plugs condensed to the level of the free gingival margin.

Sixteen subjects with seventeen graft sites consisting of one maxillary molar, four mandibular
molar, and twelve maxillary premolar intact extraction sockets were analyzed for changes in
horizontal and vertical hard tissue changes following one of two surgical interventions. Seven of
these teeth were extracted due to caries, eight due to fracture and non-restorability, and two due
to endodontic failure.

Horizontal Change – Primary Outcome Variable
Baseline and re-entry measurements were taken of buccal-lingual ridge width 3mm apical to the
facial osseous crest at the mesial, center, and distal of each study site using two methods: clinical
bone sounding with calipers and radiographic measurements made on sagittal slices of a limited
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field of view cone beam computerized tomographic scan utilizing an acrylic 0.040 vacuform
stent with gutta markers marking each measurement location.
Pairwise correlations revealed a high correlation among horizontal ridge changes at the mesial,
center, and distal clinical measurements of each site (Center-Mesial – 0.87; Distal-Mesial – 0.75;
Distal-Center – 0.82), thus the composite mean of each site was used for comparison between
treatment groups—Table 2. The study failed to detect a difference clinically between treatment
groups (control – 1.88mm± 1.51; test – 2.02mm±2.17; mean±SD) —Table 3. The study also
failed to detect a difference radiographically between treatment groups (control – 1.40mm± 0.72;
test – 0.87mm±0.64; mean±SD) —Table 4. Using the mean clinical horizontal change as the
response variable, the effects of mean buccal plate, surgical intervention, total cholesterol,
vitamin D, and time between surgeries on the response variable were evaluated and no statistical
significant effects were found. After adjusting for the above variables, the mean horizontal
changes between treatment groups were again, non-significant (control – 1.95± 0.66; test – 1.94±
0.71; least square mean ± SE) —Table 5. This process was also conducted with the radiographic
horizontal measurements and compared between treatment groups. Again, no statistical
differences were observed between groups in mean radiographic horizontal changes.

Vertical Changes – Secondary Outcome Variable
Clinical bone sounding measurements with a UNC-15 periodontal probe and radiographic
measurements on sagittal slices of a limited field-of-view cone beam computerized tomographic
image were made at the mesiobuccal, distobuccal, mesiolingual, and distolingual line angles of
each study site and baseline and re-entry utilizing the pre-described acylic stent. Relative clinical
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measurements were made to the top of the acrylic stent. Relative radiographic measurements
were made utilizing radiographic gutta percha makers within the acrylic stent.
Pairwise correlations revealed significant correlation between vertical changes at the mesio- and
disto-lingual line angles only (Distolingual-Mesiolingual-0.80) —Table 6. Therefore a mean of
these two variables was used for the compare lingual vertical change. Mesiobuccal (MB) and
distobuccal (DB) measurements were analyzed separately. No statistical difference due to
treatment was detected clinically between groups on the lingual (control – -0.11±2.11; test – 0.88±1.36; mean±SD) or MB (control – -0.44±2.11; test – -0.31± ±1.39; mean±SD) or DB
(control –- 0.33±0.90; test – -0.38±2.20; mean±SD) line angles—Table 7. No differences were
seen radiographically as well (control – -1.49±0.95; test – -0.99±0.57; mean±SD) or MB (control
– -0.58±1.06; test – -0.41±0.85± ±1.39; mean±SD) or DB (control –-0.70±0.92; test – 1.01±0.85; mean±SD)—Table 8. No significant effects of intervention, total cholesterol, vitamin
D, mean buccal plate, or time between surgeries were detected when using the mean lingual
vertical change as the response variable. After adjusting for the above variables the least square
means were non-significant between treatment groups (control – 0.12±0.66; test - -1.14±0.70;
mean±SD) —Table 9. Analysis of the radiographic vertical changes also failed to detect a
difference due to intervention at the four line angles measured.
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Discussion

In 1975 Pietrokovski3, in an attempt to determine the direction of buccal lingual ridge
loss after dental extraction, reported post-extraction ridge width losses of 8.37mm and 7.48mm
for maxillary and mandibular first molars, 4.20mm and 4.03mm for maxillary and mandibular
second premolars, and 5.37 and 4.85 for maxillary and mandibular first premolars. These
measurements were obtained on soft tissue casts made of patients who had a single missing tooth
and were compared to the intact contralateral site using graph paper. He determined that greater
resorption occurred on the buccal side of the socket although the absolute amounts and
differences vary widely.
Several variables that influence post-extraction ridge dimension changes have been
identified since Jaime Pietrokovski’s work that were unaccounted for in his report, although he
was aware of the first: tooth location. Schropp et al.4 performed forty-six minimally traumatic
single tooth extractions on premolars and molars. The widest point of the ridge was measured on
soft tissue models at baseline, three, six and twelve months. At three months there was an overall
loss of 3.8mm with premolars losing 3.1mm and molar sites losing 4.5mm. These figures are
lower than that of Pietrokovski most likely due to a controlled, minimally-traumatic method of
extraction that was not controlled for previously. This variable difference in ridge dimension
change due to location has also been reported in alveolar ridge preservation studies by the
University of Louisville49. They report a mean loss of 1.4±1.1mm (n=99) in maxillary premolar
sites and a loss of 0.4±1.0mm (n=24) in mandibular premolar sites.
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In the present study seven of eight sites in the L-PRF group were maxillary premolars
along with one mandibular molar. Five sites in the FDBA group were maxillary premolars along
with one maxillary molar and three mandibular molars.
Even within a single tooth location, there appears to be a varying response postextraction, whether preservation was employed or not. One of the potentially largest variables
influencing the degree of resorption is the status and thickness of the buccal plate. The work by
Schropp et al4 may have checked for buccal plate integrity but there is no mention of this within
the materials and methods. Sites that had a very thin or absent cortical plate may have skewed
the data, something the mean would mask. This is evident by one quarter of the sites losing
5.2mm and three quarters of the sites losing 2.3mm. Most of this variation was seen in the molar
sites where minimally traumatic extraction is more difficult. More resorption was seen in
mandibular molars than maxillary molars but both sites had great variation.
Spinato et al6 examined the effect of thin (<1mm) versus thick (≥1mm) buccal plates on
resorption, with or without a socket graft of FDBA covered with a rapidly resorbing type I
collagen dressing and no primary closure. Thirty one single rooted sites with intact buccal plates
post-extraction were examined. At four months the authors noted that all the grafted sites
resorbed less, regardless of buccal plate thickness. Sites with thin buccal plates resorbed more
than sites with thick buccal plates in both the grafted and extraction alone sites. The most
resorption, therefore, was seen in ungrafted sites with thin buccal plates (2.67±0.52mm,
mean±SD) and the least in thick grafted sites (0.125±0.35mm, mean±SD).
In the present study there were more molar sites enrolled into the FDBA group, but the
mean buccal plate thickness was slightly larger in the L-PRF group although this difference was
not significant. There was, however, a wide range of buccal plate thicknesses encountered in
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both groups with values ranging from 0.69mm to 2.98mm in the FBDA group and 0.60mm to
3.40mm in the L-PRF group. The high buccal plate measurements typically occurred due to the
presence of buccal exostoses at 3mm apical to the facial osseous crest. The impact of buccal
plate thickness was examined in the present study. No significant effect of buccal plate thickness
could be detected utilizing ANOVA. This is most likely due to the low power and sample size of
the study.
The surgical technique can greatly influence the amount of resorption encountered postoperatively. This was another variable that was not controlled for in the Pietrovoski work.
Surgical technique can jeopardize the integrity of the buccal and or lingual cortical plates as well
as disrupt vascular supply to the healing socket. Lekovic et al10 reported a drastic reduction in
ridge width post extraction when a polygycolide/polylactide barrier membrane was employed
(1.31±0.24mm vs. 4.56±0.33mm; mean±SD). Full thickness mucoperiosteal flaps were elevated
with four vertical incisions. Primary closure was achieved in all sites. To make repeat
measurements, titanium pins were punctured through the buccal plate two to five millimeters
below the facial crest. The flap technique combined with pins through the facial plate may have
compromised the blood supply to the sites thus inducing a high amount of resorption in the
extraction alone sites.
A similar study design was employed by Barone.50 Full thickness flaps with vertical
incisions were made on non-molar teeth. Sites received extractions alone or extraction and socket
grafting with a porcine xenograft and a collagen membrane. Primary closure was achieved in all
sites. The extraction alone group lost 4.5±0.8mm, and the grafted group lost 2.5±1.2mm. The
concept of flap reflection and consequently primary or secondary closure of ridge preserved sites
was investigated by the same author in 201414. Sixty four premolar or molar sites with intact
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adjacent teeth and intact buccal plates received a porcine xenograft covered with a collagen
membrane. Thirty-two sites had no mucoperiosteal flap reflection and were left open to heal
secondarily. The other thirty-two sites were flapped on the facial with vertical incisions and
closed primarily. Sites that were closed primarily lost 3.5±0.9mm compared to 1.7±0.6mm lost
in the group left open.
Several clinical studies have been performed on single rooted teeth with a variety of
techniques. Iasella et al11 studied twenty-four single rooted extraction sockets that received an
intrasocket graft of FDBA and a bioresorbable collagen membrane or extraction alone. Full
thickness flaps were reflected in all sites and presence of buccal plate was confirmed clinically.
The authors report a horizontal loss of 2.6±2.3mm when no graft was performed compared to a
loss of 1.2±0.9mm with ridge preservation. Aimetti et al.12 recruited twenty-two single rooted
teeth to receive calcium sulfate hemihydrate as an intrasocket graft compared to eighteen
extractions alone. At three months the negative control sites lost 3.2±1.8mm compared to the
grafted group losing 2.0±1.1mm.
Beck and Mealey51 tested for histologic differences in non-molar ridges preserved with
FDBA and type I collagen at four and six months post-operatively. Although the primary
outcome of this study was histologic differences at two time points, the authors report horizontal
losses of 1.47±1.81mm in the early group and 1.43±1.89mm in the delayed group. Seeking to
determine histologic differences between FDBA and demineralized FDBA (DFDBA), Wood and
Mealey52 cite mean horizontal ridge losses of 2.09±1.71mm in the FDBA group and
2.18±1.62mm for the DFDBA group at eighteen to twenty weeks post-operatively.
Kotsakis et al.13 studied thirty two extractions randomized to receive nothing, an
intrasocket graft of bovine xenograft, or an intrasocket graft with a bone putty. No
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mucoperiosteal flaps were reflected and teeth were extracted in a minimally traumatic fashion.
Sites receiving nothing lost a mean of 2.53mm. Sites receiving bovine xenograft lost a mean of
1.39mm, and those receiving allograft bone putty lost a mean of 1.26mm. And finally, data
presented from Master’s Theses from the University of Louisville report an average loss of
1.41±1.1mm in premolar sites that were preserved. 49
Due to the varied responses following extractions and ridge preservation procedures in
the literature, the authors of the current pilot trial employed very narrow inclusion/exclusion
criteria in an attempt to control for these noted variables. We also explored potential emerging
systemic variables in an attempt to explain the variable post-operative responses. All sites
recruited for the present study were premolars or molars. All sites were bordered on both sides
by intact teeth with intact periodontal ligaments. Only one consecutive tooth was extracted. On
the one patient that received two extractions, they were on the contralateral sides of the arch.
Immediately following extraction, the buccal plate was checked for integrity not only clinically
but radiographically as well. All extractions were performed in a minimally traumatic manner
with absolutely no mucoperiosteal flap reflection and no attempt at primary closure. In addition,
serum cholesterol and 25-hydroxyvitamin-D3 levels were assessed in all subjects.
25-hydroxyvitamin-D3 is a hepatic prehormone whose serum concentrations can be used
to detect how much vitamin D is in the body with normal values between thirty and one
hundered nanograms per milliliter. Preclinical animal data suggests that 25-hydroxyvitamin-D3
plays an active role in bone healing and metabolism. Jinguishi et al.19 showed that 1,25(OH)2Vitamin D3, a biologically active metabolite of serum 25(OH)Vitamin D3 that is produced in the
kidneys, localizes from the plasma to the site of fractured femurs in rats as measured by
administering H3-1,25(OH)2-Vitamin D3 and measuring via autoradiography and high-
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performance liquid chromatography. The administration of 25-OH Vitamin D is capable of
improving the mechanical strength of femoral post-fracture calluses in elderly rats as measured
by maximum torque of induced fractures at 5 weeks post-op, when the rats were anesthetized.
Serum 25-OH Vitamin D levels were measured in both a control and test group preoperatively
and at death. The test group was administered 250IU/100g weight of 25-OH Vitamin D
subcutaneously at time of fracture and 150IU/100g weight at day 15 and day 30 to bring their
average levels to 16.7±5.3ng/mL at death. The test group showed statistically significant greater
maximum torque values as measured by a Student’s t test with an accepted level of significance
set at p<0.05 with 95% CI. The authors state that the differences were so great between groups,
statistical significance was achieved with a relatively small number of animals. There was a
positive correlation between values of the maximum torque of the healing femora and blood
levels of 25-OH Vitamin D at death (p<0.01; r=0.55 via Pearsons correlation for linear
regression 95% reliability).18
Kelly et al.16 used a rat implant osseointegration model to show that 25-hydroxyvitaminD3 insufficiency negatively impacts peri-implant bone formation, osseointegration, implant
stability, and bone to implant contact. The authors placed 28 implants with two different surfaces
in 10 rats that were divided into control rats and test rats. The test rats went 4 weeks with a
complete lack of sunlight and a Vitamin-D absent diet. Serum levels of 1,25-hydroxyvitamin-D3
and 25-hydroxyvitamin-D3 were measured at sacrifice which was fourteen days after implant
placement. 1,25-hydroxyvitamin-D3 levels were not significantly different between groups,
however, 25-hydroxyvitamin-D3 were (control = 19.1±9.7ng/mL; test = 1.9±0.6ng/mL;
mean±SD). Implant osseointegration was measured via a push in test in which an appliance
applied a unidirectional force up to 2000N onto the implant head that is embedded in the en-
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block sectioned femur that was embedded in acrylic. A raw value was determined by measuring
the peak of the load-displacement curve. This was followed by scanning electron microscopic
(SEM) observation and bone to implant contact (BIC) measured at the cortical region of the
implant. The push-in values were as follows: Control Acid Etched - 24.99±7.92N, Test-Acid
Etched – 15.94±8.20N; Control HA+AE-37.48±17.58N, Test HA+AE-15.63±3.96. The bone to
implant contact values were as follows: Control AE-69.06±11.79%, Test-AE-45.89±13.49%;
Control HA+AE-70.31±6.95%, Test HA+AE-38.13±5.25. The differences between test and
control implants were statistically significant for bone to implant contact and push-in values. The
authors note that under SEM, there were no differences in marrow space but the Vitamin-D
insufficient group showed an unusual soft tissue interface at the implant surface in the cortical
area that was not seen in the control group. It has also been shown that repleting vitamin-D levels
following induced deficiency improves peri-implant bone formation in rats.
Dvorak et al.17 induced vitamin-D deficiency in a group of rats and compared BIC values
and fluorescence labeling to a group of controls and a depletion-repletion group. They showed
that vitamin-D depletion is associated with significant decreases in bone to implant contact in the
cortical area (59.68%) compared to controls (76.30%) but not compared to their depletionrepletion group (64.88%). There were no significant differences detected for fluorescence
labeling among groups, although vitamin-D receptors were localized to the PDL, cementoblasts,
gingiva, and bone-associated cells.
Orthopedic epidemiological data support an association between serum 25hydroxyvitamin-D3 levels and the need for particular orthopedic procedures. Stoker et al21 found
that eighty-four percent of patients undergoing spinal fusion surgery from 2010 to 2013 had
some vitamin-D abnormality. Fifty-seven percent of subjects were defined as having 25-
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hydroxyvitamin-D3 inadequacy (<30ng/mL) and twenty-seven percent having deficiency
(<30ng/mL). The authors concluded that they revealed a substantially high prevalence of vitamin
D abnormality in adults undergoing spinal fusion, and although age is a well-established risk
factor for hypovitaminosis, young adults undergoing spinal fusion should not be overlooked with
regard to vitamin D screening.
Another report from the orthopedic literature supports the same conclusion. Brinker et
al22 report that of six hundred eighty three patients treated for non-unions of fractured long bones
from 1998 to 2005, thirty-seven with unexplainable etiology were referred to endocrinologists
for evaluation. Of the thirty seven patients referred, thirty one had undiagnosed endocrine or
metabolic abnormalities. The most common diagnosis was vitamin-D deficiency. In addition,
non-unions spontaneously healed by vitamin-D supplementation in eight of the twenty five
patients diagnosed with vitamin-D deficiency.
NHANES data gathered from 1988 to 1994 compared to data gathered from 2001-2004
support that 25-hydroxyvitamin-D3 insufficiency and deficiency are prevalent in the United
States. The mean serum 25-hydroxyvitamin-D3 level was thirty nanograms per milliliter during
NHANES III and decreased to twenty-four nanograms per milliliter during NHANES 20012004. The prevalence of 25-hydroxyvitamin-D3 levels of less than ten nanograms per milliliter
(frank deficiency) increased from two percent to six percent. The prevalence of levels thirty
nanograms per milliliter or more (normal) decreased from fourty-five percent to twenty-three
percent. The current prevalence of Vitamin D abnormalities in the United States population is
estimated at seventy-seven percent (74-80%, 95%CI).20
In the present study, serum levels of 25-hydroxyvitamin-D3 were non-significant between
groups at baseline and seemed to have a limited effect on the post-extraction ridge dimension
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changes. This may have been due a low sample size. The mean serum level of 25hydroxyvitamin-D3 in the present study was 31.12±10.58ng/mL with a range of 15.7-50.2
ng/mL. Vitamin-D abnormality was found in ten of the sixteen subjects with a prevalence of
sixty-five percent. These levels were non-significant at baseline between treatment groups.
Bone marrow stromal cell populations contain mesenchymal stem cells capable of
differentiating into osteoblastic or adipocytic lineages. Cholesterol can determine the pathway.
In addition, diet that increases cholesterol can alter marrow lipid composition and determine
marrow cell phenotypes. Parhami et al.25 investigated the ability of minimally oxidized low
density lipoprotein (MM-LDL) to inhibit osteoblastic activity as well as the ability of lipid to
change marrow stromal cell phenotype. MM-LDL inhibits osteoblastic differentiation of the
murine marrow stromal cell line. This inhibition is mediated through a MAP kinase signaling
pathway. MM-LDL enhances adipogenic differentiation of marrow stromal cells in the presence
of free fatty acids, thiazolidinediones, and other peroxisome proliferator-activated receptorgamma activators. The peroxisome proliferator-activated receptor-gamma is the “master
controller” of adipocytic differentiation and triggers an intracellular cascade leading to fat
droplet accumulation in the cytoplasm. Mice that were fed a high fat, atherogenic diet displayed
increased proliferation and inhibited osteogenic potential of their marrow stromal cells in vitro
compared to controls as determined by reductions in alkaline phosphatase, collgen I expression,
and mineralization assays. The authors suspect that changes in dietary fat may alter marrow lipid
composition and subsequently influence marrow stromal cell phenotypes. They conclude that
inhibition of osteogenesis and promotion of adipogenesis by lipids and oxidized lipids may
contribute to the paucity of mature osteoblasts and excess adipocytes in osteoporotic bone. LDL
has also been shown to be cytotoxic to osteoblasts in vitro.23
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The clinical effect of hyperlipidemia has been demonstrated in rats.24 Fifty rats were
divided into two groups: normal (ND) and high fat diet (HFD) (19.77% vs. 59.28% fat). Rats
were sacrificed at twelve weeks. Two and three-dimensional images were taken of the mandibles
and compared between groups. The high-fat diet group demonstrated a decline in bone formation
and an increase in mandibular porosity in both 2D and 3D micro-CT images compared to rats on
a normal diet. The 3D micro-CT analysis revealed a significantly greater ratio of bone volume to
total volume and trabecular thickness and significantly less percent porosity in the ND group,
whose plasma cholesterol was (90.80 ± 4.33mg/dl; n=25) compared to the HFD group
(136±7.36mg/dl). For note, the normal diet rats weighed 1.01lbs and the HFD rats 1.20lbs. LDL
and total cholesterol can be used as markers of a high fat diet that has been demonstrated to
cause not only clinically detectable bone abnormalities but also impaired osteoblastic function in
vitro.
Medications that are presently used in humans to lower serum cholesterol levels have
been shown to inhibit bone loss and RANKL expression as well as increase bone-morphogenetic
protein-2 in rates with experimental ligature-induced periodontitis.53 Although less significant,
this effect has also been demonstrated in humans.54 Atorvastatin, an inhibitor of hepatic
cholesterol synthesis, was administered to hyperlipidemic patients at twenty milligrams per day
for three months. This was compared to a matched placebo group. The test group demonstrated
lowered LDL and total cholesterol levels, increased alveolar bone height, and decreased CEJ to
alveolar bone distance compared with measurements from the negative control group. Bone
mineral density (BMD) of the calcaneus bone (heel bone) in the test group increased from
21.5±7.7mm2 to 26.3±6.9mm2. Although not statistically significant, the study was not designed
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to test for differences in this parameter and was most likely underpowered to detect a difference.
There was no increase in BMD for the control group.
Similar to the findings with 25-hydroxyvitamin-D3, serum LDL and total cholesterol
levels had minimal significance on the outcomes measured in the present study. This again was
most likely due to the low sample size and power. Pairwise correlations revealed a high
correlation between LDL and total cholesterol levels, therefore, only total cholesterol was used
in the statistical analysis. The mean prevalence of hyperlipidemia in the present study was thirtyeight percent.
Leukocyte-Platelet Rich Fibrin (L-PRF) is a three-dimensional heterogenous fibrin “clot”
that contains >97% of platelets and >50% of leukocytes present in a nine milliliter whole venous
blood draw.26 It is obtained by drawing whole venous blood into a glass or plastic vacutainer
containing no anticoagulants or biomodifiers. The nine milliliter blood sample is immediately
centrifuged table-top for twelve minutes at twenty-seven hundred revolutions per minute. This
produces three layers within the vacutainer: a red corpuscle base at the bottom, the L-PRF layer
in the middle, and platelet poor plasma at the top. The natural fibrin polymerization method
combined with the centrifugal force enables entrapment of growth factors from platelets and
cytokines from leukocytes into the fibrin matrix.28 L-PRF has been shown to release the growth
factors TGFβ-1, PDGF-αβ, VEG-F, and thrombospondin-1, an important coagulation
glycoprotein of the cellular matrix, for 7 days after its preparation.29 L-PRF provides a suitable
substrate for cell growth and division. It has been shown to stimulate cell growth and replication
of human osteoblast-derived-osteoscarcoma cells, human kertinocyte-derived carcinoma cells,
and human fibroblast lung carcinoma cells, and to upregulate osteocalcin and ostepoontin (bone
sialoprotein-1) in human osteoblast-derived osteosarcoma cells in vitro. 27
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One of the first clinical uses of L-PRF studied in the literature was its combination with
FDBA in maxillary sinus augmentations.31 Six cases of maxillary sinus augmentation with LPRF and FDBA were performed and compared to three sinus augmentations with FDBA alone.
The sites with L-PRF and FDBA were re-entered at four months to place implants and harvest
bone core biopsies. These were compared to cores taken at eight months in the FDBA group. The
authors found no differences between treatment groups. Both groups showed a mean of twenty to
twenty one percent vital bone and between nine and eleven percent non-vital bone.
Three years later a similar study was completed using only L-PRF as the sole graft
material in maxillary sinus augmentations. Mazor et al32 completed twenty five lateral window
sinus elevations on twenty patients. Radiographic analysis was made on CBCT images taken
immediately preoperatively and six months post-operatively to determine changes in bone
height. Nine bone cores were retrieved six months postoperatively for histologic analysis. Forty
one implants were placed uneventfully. All implants survived and were clinically stable during
abutment tightening at twenty-five newton centimeters. All biopsies showed well organized and
vital bone (33±5%, mean±SD). Because only L-PRF was used, all biopsies showed one hundred
percent vital bone. Bone height gained was between seven and thirteen millimeters
(10.1±0.9mm; mean±SD).
The effect of L-PRF was studied in third molar extraction sites. Gurbuzer et al.30
performed a split mouth prospective trial comparing osteoblastic activity in vertical soft tissue
impacted third molar extraction sites receiving either L-PRF or nothing. Primary closure was
achieved in all sites. Four weeks post-operatively all patients received intravenous injection of
555MBq technetium-99m methylene diphosphonate and static oblique images were taken of the
left and right extraction sockets. No differences were detected scintigraphically. The average
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uptake of technetium-99m was 4.54±1.03 for the L-PRF group and 4.61±1.02 in the negative
control group. The authors conclude that L-PRF does not seem to increase bone healing within
extraction sockets of soft tissue impacted mandibular third molars 4 weeks after surgery.
The effect of L-PRF on guided tissue regeneration (GTR) has been documented by at
least five recent controlled prospective clinical trials, three of which examine intrabony
defects35, 36, 37 and two examining mandibular class II furcation defects.33, 34 The first study
compared open flap debridement (OFD) to OFD plus a graft consisting of L-PRF covered with
an L-PRF membrane.36 Sites enrolled were first or second mandibular molars with an intrabony
defect depth of at least three millimeters and a probing depth of at least five millimeters.
Differences between treatment groups were compared radiographically and clinically at nine
months. For all the parameters, the test group performed better than the negative control group.
These differences were found to be statistically significant. The mean bone fill was greater in the
L-PRF group (46.92% vs. 28.66%). Mean probing depth reduction was greater (4.56±0.37mm vs
3.56±0.27mm; mean±SD), and clinical attachment loss gain was greater (3.69±0.44mm vs.
2.13±0.43mm; mean±SD) in the L-PRF group. The authors conclude that within the limitations
of their study design, there was a greater reduction in probing depth, more clinical attachment
gain, and greater intra-bony defect fill at sites treated with L-PRF than for OFD alone.
Sharma et al35 studied three walled intrabony defects measuring at least three millimeters
deep radiographically and probing at least five millimeters clinically. Seventeen patients
supplying twenty eight sites were randomized to the control, open flap debridement (OFD)
group. Eighteen patients supplying twenty-eight study sites received OFD plus the placement of
L-PRF as described above. At nine months, differences between the treatment groups were
compared. Statistically significant differences in probing depth reduction, gingival margin level,
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and defect fill were detected, with the L-PRF group outperforming the OFD alone group. The
greatest of these differences was for percent bone fill. The L-PRF group showed a 48.26±5.72%
bone fill at nine months compared to 1.80±1.56% in the OFD alone group. The authors conclude
that there was greater probing depth reduction, attachment level gain, and bone fill at sites
treated with L-PRF compared to those treated with conventional open flap debridement.
The same group later completed a similar study comparing L-PRF to platelet rich plasma
(PRP) in intrabony defects.37 The authors observed similar probing depth reduction, clinical
attachment level gain, and bone fill at sites treated with L-PRF or PRP. These results were
statistically significantly better than the negative control group of open flap debridement alone.
The authors conclude that because L-PRF is less time consuming, less technique sensitive, and
less expensive, it may seem to be a better treatment option than PRP.
The effect of L-PRF has been studied in the treatment of mandibular class II furcation
defects in two trials. Sharma and Pradeep33 used a split mouth design to enroll thirty six
mandibular class II furcation defects. Sites were randomly assigned to test or control groups. The
authors found that all clinical and radiographic parameters were statistically significantly
improved in sites treated with PRF and open flap debridment (OFD) compared to OFD alone.
Bajaj et al34 confirmed these findings in a subsequent trial. Seventy-two mandibular class II
furcation defects were enrolled to be treated with open flap debridement (OFD), PRP with OFD,
or L-PRF with OFD. Sites were examined clinically and radiographically. At nine months, all
clinical and radiographic parameters showed statistically significant improvement over OFD
alone.
L-PRF itself has minimal space maintaining properties although it has been shown to
have drastic biological effects in vitro.26-29 Therefore we designed the present study to utilize
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intact posterior extraction sites as a clinical model for a four-walled defect to test a spacemaintenance method against a biological method for preventing ridge collapse. It was important
in our pilot study to minimize noted variables that influence post-extraction resorption, namely,
surgical technique, presence of an intact buccal plate, and intact adjacent periodontal ligaments.
At no point during our statistical analysis did we find any significant differences due to
treatment. The clinical and radiographic means of horizontal ridge changes are well within the
expected ranges as reported in the literature for ridge preservation procedures. The vertical mean
changes, although less focused on in the current study, were also well within reported means.
The main limitation of the current pilot study is low sample size. Poulias et al49
performed an a priori power analysis based on ridge width changes in non-molars and calculated
they needed a sample size of eleven per group to give an eighty percent statistical power to
detect a difference of 1mm between treatment groups. Even with adequate power, they observed
a wide range of results. The reported change over four months was 1.6±0.8mm ranging from a
loss of 3.4mm to 0.5mm. The same situation was seen in the current study. There appeared to be
similar means between groups but a wide variation of responses that appeared to be independent
of any of the predictor variables we measured. Similar standard deviations are seen as the sample
size is increased. Barone et al14 enrolled sixty four premolar and molar sites randomized to two
groups: flapless with secondary closure or flapped with primary closure following extractions.
Both groups received an intrasocket graft of porcine xenograft and a collagen barrier. Flapless
sites resorbed 1.7±0.6mm and the flapped sites resorbed 3.5±0.9mm, again demonstrating the
wide variability of responses.
Measurements in the current study were made clinically with a caliper and
radiographically on sagittal slices of a limited field of view CBCT image. Although the same
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conclusion can be made by using the clinical or radiographic data alone, the actual measurements
were not well correlated with the exception of buccal plate thickness. One potential source of
error may be the use of gutta percha as radiographic markers. According to Lund et al41 the use
of gutta percha is controversial due to low opacity and dimensional instability. The authors of the
present study agree with this statement.
Several authors have examined the correlation between physical measurements and
measurements made on CBCT images. Loubele et al40 compared gold standard physical
measurements of an ex vivo human maxilla to measurements made on both CBCT and multislice
computed tomographic images. The accuracy of the linear measurements made on CBCT was 0/09±1.64mm. Tomasi et al42 discuss the ability to get different linear measurements on CBCT
images simply by changing the angulation of the object being scanned. They made linear
measurements on a dry human skull and then imaged this skull parallel to the horizontal plane
and at forty five degrees. The accuracy of the CBCT measurements was evaluated with
comparisons of standard deviations and estimations of intraclass correlation coefficients. They
report an intraclass correlation coefficient between CBCT measurements and physical
measurements with a caliper of 0.992mm. The absolute mean measurement error for CBCT was
0.40±0.39 (mean ± SD). The percent of error exceeding one millimeter was 6.7 percent.
Hashem et al44 compared measurements made on CBCT images taken at 360 degrees
and 180 degrees to direct measurements on twelve sectioned porcine hemimandibles. They found
good to excellent intra- and interobserver agreement. A mixed regression analysis could not
detect a statistical significant difference between either scan acquisition protocol or the direct
measurements.
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Some authors report that variation involved with linear measurements on CBCT images
may be due to voxel size.45To examine this effect, Torres et al43 evaluated four image acquisition
protocols that varied the voxel size and scan time. They compared measurement error between
each protocol and direct measurements. They express their results as a percent difference of
direct measurements. They found that typical voxel sizes underestimate the true distance. They
found that in horizontal measurements there was a 16.22-17.22% difference and a 7.19-8.20%
difference in vertical measurements. This equates to around 0.68-0.72mm less than the real
distance. Although the authors hypothesized that changing the voxel size and scan time would
influence linear measurements made on the scans, they did not find any difference between
protocols.
Shokri et al 45 compared measurements made on CBCT images with slices of 0.5-, 1-, 2-,
3-, 5-, and 10-mm slice thicknesses with physical measurements made with digital calipers on
eleven dry human mandibles. They found no significant differences in bone width in any area
among any of the slice thicknesses. The only measurement they found that was not statistically
significantly different from the actual direct measurement was width using 4mm slices and
height using 5mm slices. They felt that slice thicknesses of less than 4mm may underestimate the
actual measurement. In the present study, most CBCT image measurements were made with
slice thicknesses around 0.5mm. This may explain the lack of correlation between direct
measurements and radiographic measurements, as CBCT measurements tended to be less than
clinical.
The ultimate goal of ridge grafting at time of extraction in the posterior mandible or
maxilla is to prevent ridge collapse enough to adequately place and house a dental implant,
ideally, without additional grafting at time of implant placement. Extraction sockets in the
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posterior maxilla and mandible are not typically in an esthetic area of the mouth and thus more
resorption may be tolerated. This is also true due to the fact that many posterior ridges can
tolerate even a fifty percent reduction in ridge width and still be adequately wide to receive a
dental implant. In the present study all implants were placed successfully with at least thirty
newton centimeters of torque. Additional bone graft was added to one implant in each group at
time of implant placement. All implants were successfully restored and are still in function at the
time of publication.
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Conclusions

It can be concluded that within the limitations of the current pilot study, leukocyte-platelet rich
fibrin may function similarly to mineralized freeze dried human cortical bone allograft and a
cross-linked type I porcine collagen membrane in intact posterior extraction sites when a
minimally traumatic approach is employed. However, due to the low sample size in the current
study, no definitive conclusions can be drawn. More research is needed with a larger enrollment
and a negative control group.

32

VITA

Thomas Foster Glazier was born on October 13, 1985 in Newnan, Georgia, and is an American Citizen.
He graduated from Newnan High School in Newnan, Georgia in 2004. He received his Bachelor of
Science in biology from the University of Georgia in Athens, Georgia in 2007. He received his Doctorate
of Dental Surgery from Virginia Commonwealth University in Richmond, Virginia in 2012.

33

Literature Cited

34

1. Irinakis T, Tabesh M. Preserving the socket dimensions with bone grafting in single sites: an
esthetic surgical approach when planning delayed implant placement. J Oral Implantol
2007;33:156-163.
2. Darby I, Chen S, De Poi R. Ridge preservation: what it is and when should it be considered.
Aust Dent J 2008;53:11-21.
3. Pietrokovski J. The bony residual ridge in man. J Prosthet Dent 1975;34:456-462.
4. Schropp, L, Wenzel A, Kostopoulos L, Karning T. Bone healing and soft tissue contour
changes following single-tooth extraction: A clinical and radiographic 12-month prospective
study. Int J Periodontics Restorative Dent 2003;23:313-323.
5. Misch CE, Silc JT. Socket grafting and alveolar ridge preservation. Dentistry Today
2008;27:146-150.
6. Spinato S, Galindo-Morena P, Zaffe D, Bernardello F, Soardi CM. Is socket healing
conditioned by buccal plate thickness? A clinical and histologic study 4 months after mineralized
human bone allografting. Clin Oral Impl Res 2014;25(2):e120-e126.
7. McCall RA, Rosenfeld AL. Influence of residual ridge resorption patterns on implant fixture
placement and tooth position. Part 1. Int J Perio and Restorative Dent 1991;11: 8-23.
8. Otto M. Socket Preservation. SADJ 2006;61:366-368.
9. Cardaropoli D, Cardaropoli G. Preservation of the Postextraction Alveolar Ridge: A Clinical
and Histologic Study. Int J Perio and Restorative Dent 2008;28: 469-477.
10. Lekovic V, Camargo PM, Klokkevold PR, Weinlaender M, Kenney EB, Dimitrijevic B, and
other. Preservation of alveolar bone in extraction sockets using bioabsorbable membranes. J
Periodontol 1998;69:1044-1049.
11. Iasella JM, Greenwell H, Miller RL, Hill M, Drisko C, Bohra A, Scheetz JP. Ridge
Preservation with Freeze-Dried Bone Allograft and a Collagen Membrane Compared to
Extraction Alone for Implant Site Development: A Clinical and Histologic Study in Humans. J
Periodontol 2003;74:990-999.
12. Aimetti M, Romano F, Griga FB, Godio L. Clinical and histologic healing of human
extraction sockets filled with calcium sulfate. Int J Oral Maxillofac Implants 2009;24(5):902909.
13. Kotsakis GA, Salama M, Chrepa V, Hinrichs JE, Gaillard P. A randomized, blinded,
controlled clinical study of particulate anorganic bovine bone mineral and calcium
phosphosilicate putty bone substitiutes for socket preservation. Int J Oral Maxillofac Implants
2014;29(1):141-151.
35

14. Barone A, Toti P, Piattelli A, Iezzi G, Derchi G, Covani U. Extraction socket healing in
humans after ridge preservation techniques: comparison between flapless and flapped procedures
in a randomized clinical trial. J Periodontol 2014;85(1):14-23.
15. Agbaje JO, Jacobs R, Maes F, Michiels K, van Skenberghe D. Volumetric analysis of
extraction sockets using cone beam computed tomography: a pilot study on ex vivo jaw bone. J
Clin Periodontol 2007;34:985-990.
16. Kelly J, Lin A, Wang CJ, Park S, Nishimura I. Vitamin D and Bone Physiology:
Demonstration of Vitamin D Deficiency in an Implant Osseointegration Rat Model. J
Prosthodont 2009;18:476-478.
17. Dvorak G, Fügl A, Watzek G, Tangl S, Pokorny P, Gruber R. Impact of dietary vitamin D on
osseointegration in the ovariectomized rat. Clin Oral Impl Res 2012;23:1308-1313.
18. Delgado-Martinez AD, Martinez ME, Carrascal MT, Rodriguez-Avial M, Munuera L. Effect
of 25-OH Vitamin D on Fracture Healing in Elderly Rats. J Orthop Res 1998;16(6):650-653.
19. Jinguishi S, Iwaki A, Higuchi O, Azuma Y, Ohta T, Shida JL, Isumi T, Ikenoue T, Sugioka
Y, Iwamoto Y. Serum 1-alpha-dihydroxyvitamin D3 accumulates into the fracture callus during
rat femoral fracture healing. Endocrinology 1998; 139(4):1467-1473.
20. Ginde AA, Liu MC, Camargo CA Jr. Demographic Differences and Trends of Vitamin D
Insufficiency in the US Population, 1988-2004. Arch Intern Med 2009;169(6):626-632.
21. Stoker GE, Buchowski JM, Bridwell KH, Lenke LG, Riew KD, Zebala LP. Preoperative
Vitamin D Status of Adults Undergoing Surgical Spinal Fusion. SPINE 2013;38:507-515.
22. Brinker MR, O’Connor DP, Monla YT, Earthman TP. Metabolic and Endocrine
Abnormalities in Patients with Nonunions. J Orthop Trauma 2007;21:557-570.
23. Klein BY, Rojansky N, Ben-Yehuda A, Abou-Atta I, Abedat S, Friedman G. Cell Death in
Cultured Human Saos2 Osteoblasts Exposed to Low-Density Lipoprotein. J Cell Biochem
2003;90:42-58.
24. Pramojanee SN, Phimphilai M, Kumphune S, Chattipakorn N, Chattipakorn SC. Decreased
Jaw Bone Density and Osteoblastic Insulin Signaling in a Model of Obesity. J Dent Res
2013;92(6):560-565.
25. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL. Atherogenic diet
and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic
differentiation of marrow stromal cells. J Bone Miner Res 1999;14(12):2067-2078.
26. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional
architecture and cell composition of a Choukroun’s platelet rich fibrin clot and membrane. J
Periodontol 2010;81(4):546-555.
36

27. Clipet F, Tricot S, Alno N, Massot M, Solhi H, Cathelineau G, Perez F, De Mello G, PellenMussi P. In vitro effects of Choukroun's platelet-rich fibrin conditioned medium on 3 different
cell lines implicated in dental implantology. Implant Dent 2012;21(1):51-56.
28. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich
fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features.
Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2006;101(3):e45-e50.
29. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth
factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): A gold standard to
achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27(1):63-69.
30. Gurzbuzer B, Pikdoken L, Tunali M, Urhan M, Kucukodaci Z, Ercan F. Scintigraphic
evaluation of osteoblastic activity in extraction sockets treated with platelet-rich fibrin. J Oral
Maxillofac Surg 2010;68(5):980-989.
31. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ,
Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part
V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg
Oral Med Oral Pathol Oral RadiolEndod. 2006;101(3):299-303.
32. Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Erhenfest DM. Sinus
floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin
as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol
2009;80:2056-2064.
33. Sharma A, Pradeep AR. Autologous platelet-rich fibrin in the treatment of mandibular degree
II furcation defects: a randomized clinical trial. J Periodontol 2011;82(10):1396-1403.
34. Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, Kalra N. Comparative
evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of
mandibular degree II furcation defects: a randomized controlled clinical trial. J Periodontal Res
2013;48(5):573-581.
35. Sharma A, Pradeep AR. Treatment of 3-wall intrabony defects in patients with chronic
periodontitis with autologous platelet rich fibrin: a randomized controlled clinical trial. J
Periodontol 2011;82(12):1705-1712.
36. Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the
treatment of intra-bony defects: a controlled clinical trial. J Clin Periodontol 2011;38(10):925932.
37

37. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of
autologous platelet-rich fibrin and platelet rich plasma in the treatment of 3-wall intrabony
defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol 2012;
83(12):1499-1507.
38. Agbaje JO, Jacobs R, Maes F, Michiels K, van Skenberghe D. Volumetric analysis of
extraction sockets using cone beam computed tomography: a pilot study on ex vivo jaw bone. J
Clin Periodontol 2007; 34:985-990.
39. Lascala CA, Panella J, Marques MM. Analysis of the accuracy of linear measurements
obtained by cone beam computed tomography (CBCT-NewTom). Dentomaxillofac Radiol
2004;33:291-294.
40. Loubele M, Van Asasche N, Carpentier K, Maes F, Jacobs R, van Steenberghe D, Suetens P.
Comparative localized linear accuracy of small-field cone-beam CT and multislice CT for
alveolar bone measurements. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2008;105(4):512-518.
41. Lund H, Gröndahl K, Gröndahl HG. Accuracy and precision of linear measurements in cone
beam computed tomography Accuitomo tomograms obtained with different reconstruction
techniques. Dentomaxillofac Radiol 2009;38(6)379-386.
42. Tomasi C, Bressan E, Corazza B, Mazzoleni S, Stellini E, Lith A. Reliability and
reproducibility of linear mandible measurements with the use of a cone-beam computed
tomography and two object inclinations. Dentomaxillofac Radiol 2011;40(4):244-250.
43. Torres MG, Campos PS. Accuracy of linear measurements in cone beam computed
tomography with different voxel sizes. Implant Dent. 2012;21(2):150-155.
44. Hashem D, Brown JE, Patel S, Mannocci F, Donaldson AN, Watson TF, Banerjee A. An in
vitro comparison of the accuracy of measurements obtained from high- and low-resolution conebeam computed tomography scans. J Endod 2013;39(3):394-397.
45. Shokri A, Khajeh S. In vitro comparison of the effect of different slice thicknesses on the
accuracy of linear measurements on cone beam computed tomography images in implant sites. J
Craniofac Surg 2015;26(1):157-160.
46. Tal H, Moses O. A comparison of panoramic radiography with computed tomography in the
planning of implant surgery. Dentomaxillofac Radiol 1991;20:40-42.
47. Sukovic P. Cone beam computed tomography in craniofacial imaging. Orthod Craniofacial
Res 2003;6(Suppl.1):31-36.
48. Kobayashi K, Shimoda S, Nakagawa Y, Yamamoto A. Accuracy in Measurement of
Distance Using Limited Cone-Beam Computerized Tomography. Int J Oral Maxillofac Implants
2004;19:228-231.
38

49. Poulias E, Greenwell H, Hill M, Morton D, Vidal R, Shumway B, Peterson TL. Ridge
preservation comparing socket allograft alone to socket allograft plus facial overlay xenograft: a
clinical and histologic study in humans. J Periodontol 2013;84(11):1567-1575.
50. Barone A, Aldini NN, Fini M, Giardino R, Calvo Guirado JL, Covani U. Xenograft versus
extraction alone for ridge preservation after tooth removal: a clinical and histomorphometric
study. J Periodontol 2008;79(8):1370-1377.
51. Beck TM, Mealey BL. Histologic Analysis of Healing After Tooth Extraction with Ridge
Preservation Using Mineralized Human Bone Allograft. J Periodontol 2010;81:1765-1772.
52. Wood RA, Mealey BL. Histologic comparison of healing after tooth extraction with ridge
preservation using mineralized versus demineralized bone allograft. J Periodontol
2012;83(3):329-336.
53. Dalcico R, de Menezes AM, Deocleciano OB, Oriá RB, Vale ML, Ribeiro RA, Brito GA.
Protective Mechanisms of Simvastatin in Experimental Periodontal Disease. J Periodontol
2013;84(8):1145-1157.
54. Fajardo ME, Rocha ML, Sánchez-Marin FJ, Espinosa-Chávez EJ. Effect of atorvastatin on
chronic periodontitis: a randomized pilot study. J Clin Periodontol 2010;37(11):1016-1022.

39

Table 1. Baseline Study Demographics
Control

Test

FDBA + RCM

L-PRF

Overall

Sites (n)

9

8

17

Patients

8

8

16

45.50±64.71
27-74

62.75±13.13
44-84

54.13±16.96
27-84

6/2

2/6

8/8

1/5/3/0

0/7/1/0

1/12/4/0

1.21±0.75;0.69-2.98
1.06±0.97;0.50-3.50
1.36±0.61;0.63-2.47

1.49±0.88;0.60-3.40
1.40±0.79;0.50-3.00
1.59±1.01;0.70-2.70

1.32±0.78
1.27±0.91
1.45±0.78

255.13±65.07
172-374

262.63±82.52
192-435

258.88±71.90
172-435

205.13±62.94
142-304

190.25±42.49
116-248

199.06±52.44
116-304

142.38±57.88
85-232

111±27.20
64-144

126.69±46.60
64-232

28.43±9.75
15.7-40.9

33.81±15.47
21.2-50.2

31.12±10.58
15.7-50.2

14.78±1.09
13-16

18.13±6.04
15-32.5

16.35±4.42
13-32.5

Demographic

Age (years)
Mean ± SD
Range
Sex (n;males/females)
Tooth type (n;maxillary molar /
maxillary premolar / mandibular
molar / mandibular premolar)
Mean buccal plate thickness
(mm)
Clinical (mean± SD; range)
Radiographic (mean± SD; range)
Platelet count (109/L)
Mean ± SD
Range
Ref. Range (179-373)
Total Cholesterol (mg/dL)
Mean ± SD
Range
Ref. Range (100-200)
LDL (mg/dL)
Mean ± SD
Range
Ref. Range (0-130)
25-Hydroxyvitamin-D3 (ng/mL)
Mean ± SD
Range
Weeks between surgeries
Mean ± SD
Range
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Table 2. Pairwise correlations of Clinical Horizontal Measurements
Variable

by

Correlation Count

Variable

Significant
Probability

CCH

CMH

0.87

17

<0.0001*

CDH

CMH

0.75

17

0.0005*

CDH

CCH

0.82

17

<0.0001*

*All values significantly correlated
(Clinical mesial horizontal, CMH; Clinical center horizontal, CCH; Clinical distal
horizontal, CDH)
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Table 3. Clinical Horizontal Change

FDBA + RCM

Mean Horizontal
Change
(mean ± SD)

CMH

CCH

CDH

1.88±1.51

1.50±1.58

2.25±1.78

1.89±1.80

2.02±2.17

1.75±2.15

2.06±2.41

2.25±2.07

n=9

L-PRF
n=8
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Table 4. Radiographic Horizontal Change

FDBA + RCM

Mean Horizontal
Change
(mean ± SD)

CMH

CCH

CDH

1.40±0.72

1.32±0.72

1.68±1.04

1.21±0.76

0.87±0.64

1.01±0.92

1.00±0.91

0.60±0.40

n=9

L-PRF
n=8

43

Table 5. Analysis of Variance- Horizontal Ridge Width

Level
FBDA + RCM
L-PRF

Source
Mean buccal plate
thickness
Treatment
Total Cholesterol
25-Hydroxyvitamin-D3
Time Between Surgeries

p
0.287

Least Square
Mean
1.950
1.941

Standard Error

Mean

0.662
0.711

1.880
2.020
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0.994
0.336
0.271
0.165

Table 6. Pairwise Correlations of Clinical Vertical Measurements
Variable
CRVDB
CRVML
CRVDL
CRVDL
CRVDL
CRVDL

by Variable Correlation
CRVMB
CRVMB
CRVDB
CRVMB
CRVDB
CRVML

0.26
0.24
0.16
0.41
0.49
0.80

Count
17
17
17
17
17
17

Significance
Probability
0.03197
0.3576
0.5402
0.1049
0.0450*
0.0001*

*Significantly correlated
(Clinical relative vertical mesiobuccal, CRVMB, Clinical relative vertical
distobuccal, CRVDB; Clinical relative vertical mesiolingual, CRVML; Clinical
relative vertical distolingual, CRVDL)
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Table 7. Clinical Vertical Change

FDBA + RCM

Mean Lingual Vertical
Change
(mean ± SD)

Mean Mesiobuccal
Vertical Change

Mean Distobuccal
Vertical Change

-0.11±2.11

-0.44±2.11

-0.33±0.90

-0.88±1.36

-0.31±1.39

-0.38±2.20

n=9

L-PRF
n=8
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Table 8. Radiographic Vertical Change

FDBA + RCM

Mean Lingual Vertical
Change
(mean ± SD)

Mean Mesiobuccal
Vertical Change
(mean ± SD)

Mean Distobuccal
Vertical Change
(mean ± SD)

-1.49±0.95

-0.58±1.06

-0.70±0.92

-0.99±0.57

-0.41±0.85

-1.01±0.85

n=9

L-PRF
n=8
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Table 9. Analysis of Variance- Clinical Lingual Mean Vertical
Source
Total Cholesterol
Treatment
Mean Buccal Plate Thickness
Time Between Surgeries
25-Hydroxyvitamin-D3
Level
FDBA + RCM
L-PRF

Estimate Standard
Error
0.14467 0.008851
0.629981 0.533606
0.618596 0.565694
0.108618 0.112576
0.048706 0.051278

Least Square
Means
0.1223
-1.1376

48

t Ratio

Prob > ǀtǀ

1.63
1.18
1.09
0.96
0.95

0.1304
0.2627
0.2975
0.3554
0.3626

Standard Error

Mean

0.6567
0.7059

-0.1111
-0.8750

Table 10. Outcome Variables by Group

Variables

T0

FDBA + RCM
n=9
T1

Clinical
Ridge Width

10.71±1.68

8.83±1.64

1.88±1.51

9.94±2.16

7.92±1.58

2.02±2.17

Radiographic
Ridge Width

11.68±2.31

10.27±2.64

1.40±0.72

10.53±2.20

9.66±2.43

0.87±0.64

6.22±1.92

6.61±1.24

-0.39±1.43

7.53±3.12

7.88±3.07

-0.34±1.30

5.12±1.45

5.68±1.58

-0.64±0.78

4.94±1.02

5.65±1.23

-0.72±0.57

6.75±2.64

6.86±1.35

-0.11±2.11

7.13±2.76

8.00±2.60

-0.88±1.36

4.66±1.57

6.14±1.42

-1.49±0.95

4.94±1.41

5.93±1.30

-0.99±0.57

Relative
Clinical
Buccal Ridge
Height
Relative
Radiographic
Buccal Ridge
Height
Relative
Clinical
Lingual
Ridge Height
Relative
Radiographic
Lingual
Ridge Height

Δ
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T0

L-PRF
n=8
T1

Δ

Table 11. Overall Mean Changes by Group

FDBA + RCM

Horizontal

Vertical

1.64±0.91

-0.657±0.832

1.43±1.25

-0.731±0.458

n=9

L-PRF
n=8
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Figure 1. Measurement Stent
a. Radiographic/Clinical measurement stent – Occlusal view; b. Radiographic/Clinical
measurement stent – Buccal view

51

Figure 2. Radiographic Horizontal Measurements
a. Test Group – immediately post-extraction; b. Test Group – at implant placement; c. Control
Group – immediately post-extraction; d. Control Group – at implant placement.

a.

b.

c.

d.
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Figure 3. Radiographic Vertical Measurements
a. Test Group –immediately post-extraction; b. Test Group – at implant placement; c. Control
Group –immediately post-extraction; d. Control Group –at implant placement.
a.

b.

c.

d.
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Figure 4. L-PRF Surgical Group
a. Extraction – Occlusal view; b. Completed graft – Occlusal view; c. Implant placement –
Occlusal view; d. Implant placement – buccal view; e. Implant placement – flap
reflected; f. Implant placement – implant in place; g. Table-top centrifuge; h. Whole
venous blood draw; i. L-PRF armamentarium; j. Blood immediately after twelve minute
spin; k. L-PRF layer being removed from vacutainer; l. Removal of red blood cell layer;
m. PRF Box – fabrication of L-PRF plugs; n. L-PRF plug being transferred to socket
a.

b.

e.

f.

i.

m.

c.

d.

g.

j.

h.

k.

n.
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l.

Figure 5. FDBA + Resorbable Collagen Membrane Group
a. Extraction – Occlusal view; b. Extraction – Buccal view; c. Completed graft – Occlusal
view; d. Completed graft – Buccal view; e. Two Week Postoperative – Occlusal view; f.
Implant placement – Occlusal view; g. Implant placement – Occlusal view; h. Freezedried bone allograft; i. Resorbable collagen membrane
a.

b.

c.

d.

e.

f.

g.

h.

i.
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